It is now known, for example, that women with BRCA1 mutations have dramatically elevated risks of cancer (including ovarian (44%) and breast (71%) cancers [4]) and that high-risk surveillance and risk-reducing salpingo-oophorectomy (RRSO) decrease mortality by as much as 70% [4]. Here, BRCA1 is linked to cancer.